226 related articles for article (PubMed ID: 23412658)
1. Potentiation of electrochemotherapy by intramuscular IL-12 gene electrotransfer in murine sarcoma and carcinoma with different immunogenicity.
Sedlar A; Dolinsek T; Markelc B; Prosen L; Kranjc S; Bosnjak M; Blagus T; Cemazar M; Sersa G
Radiol Oncol; 2012 Dec; 46(4):302-11. PubMed ID: 23412658
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma.
Sedlar A; Kranjc S; Dolinsek T; Cemazar M; Coer A; Sersa G
BMC Cancer; 2013 Jan; 13():38. PubMed ID: 23360213
[TBL] [Abstract][Full Text] [Related]
3. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status.
Ursic K; Kos S; Kamensek U; Cemazar M; Miceska S; Markelc B; Bucek S; Staresinic B; Kloboves Prevodnik V; Heller R; Sersa G
J Control Release; 2021 Apr; 332():623-635. PubMed ID: 33705828
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependent.
Lisec B; Markelc B; Ursic Valentinuzzi K; Sersa G; Cemazar M
Front Immunol; 2023; 14():1189960. PubMed ID: 37304301
[TBL] [Abstract][Full Text] [Related]
5. Controlled systemic release of interleukin-12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas.
Tevz G; Kranjc S; Cemazar M; Kamensek U; Coer A; Krzan M; Vidic S; Pavlin D; Sersa G
J Gene Med; 2009 Dec; 11(12):1125-37. PubMed ID: 19777440
[TBL] [Abstract][Full Text] [Related]
6. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer.
Sersa G; Teissie J; Cemazar M; Signori E; Kamensek U; Marshall G; Miklavcic D
Cancer Immunol Immunother; 2015 Oct; 64(10):1315-27. PubMed ID: 26067277
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral cisplatin administration in electrochemotherapy: antitumor effectiveness, sequence dependence and platinum content.
Cemazar M; Milacic R; Miklavcic D; Dolzan V; Sersa G
Anticancer Drugs; 1998 Jul; 9(6):525-30. PubMed ID: 9877240
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant TNF-α therapy to electrochemotherapy with intravenous cisplatin in murine sarcoma exerts synergistic antitumor effectiveness.
Cemazar M; Todorovic V; Scancar J; Lampreht U; Stimac M; Kamensek U; Kranjc S; Coer A; Sersa G
Radiol Oncol; 2015 Mar; 49(1):32-40. PubMed ID: 25810699
[TBL] [Abstract][Full Text] [Related]
9. Electrogene therapy with p53 of murine sarcomas alone or combined with electrochemotherapy using cisplatin.
Grosel A; Sersa G; Kranjc S; Cemazar M
DNA Cell Biol; 2006 Dec; 25(12):674-83. PubMed ID: 17233116
[TBL] [Abstract][Full Text] [Related]
10. Treatment of spontaneous canine mast cell tumors by electrochemotherapy combined with IL-12 gene electrotransfer: Comparison of intratumoral and peritumoral application of IL-12.
Lampreht Tratar U; Milevoj N; Cemazar M; Znidar K; Ursic Valentinuzzi K; Brozic A; Tomsic K; Sersa G; Tozon N
Int Immunopharmacol; 2023 Jul; 120():110274. PubMed ID: 37216797
[TBL] [Abstract][Full Text] [Related]
11. Mathematical model of tumor volume dynamics in mice treated with electrochemotherapy.
Forjanič T; Miklavčič D
Med Biol Eng Comput; 2017 Jul; 55(7):1085-1096. PubMed ID: 27658910
[TBL] [Abstract][Full Text] [Related]
12. Tumor perfusion evaluation using dynamic contrast-enhanced ultrasound after electrochemotherapy and IL-12 plasmid electrotransfer in murine melanoma.
Brloznik M; Boc N; Cemazar M; Sersa G; Bosnjak M; Brezar SK; Pavlin D
Sci Rep; 2021 Jun; 11(1):13446. PubMed ID: 34188103
[TBL] [Abstract][Full Text] [Related]
13.
Kranjc S; Cemazar M; Sersa G; Scancar J; Grabner S
Radiol Oncol; 2017 Sep; 51(3):295-306. PubMed ID: 28959166
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of electrochemotherapy combined with peritumoral IL-12 gene electrotransfer of canine mast cell tumours.
Cemazar M; Ambrozic Avgustin J; Pavlin D; Sersa G; Poli A; Krhac Levacic A; Tesic N; Lampreht Tratar U; Rak M; Tozon N
Vet Comp Oncol; 2017 Jun; 15(2):641-654. PubMed ID: 26840222
[TBL] [Abstract][Full Text] [Related]
15. Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.
Li S; Zhang L; Torrero M; Cannon M; Barret R
Mol Ther; 2005 Nov; 12(5):942-9. PubMed ID: 15953768
[TBL] [Abstract][Full Text] [Related]
16. New era of electrochemotherapy in treatment of liver tumors in conjunction with immunotherapies.
Trotovšek B; Djokić M; Čemažar M; Serša G
World J Gastroenterol; 2021 Dec; 27(48):8216-8226. PubMed ID: 35068866
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model.
Kranjc S; Tevz G; Kamensek U; Vidic S; Cemazar M; Sersa G
Radiat Res; 2009 Dec; 172(6):677-85. PubMed ID: 19929414
[TBL] [Abstract][Full Text] [Related]
18. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model.
Raeisi E; Aghamiri SM; Bandi A; Rahmatpour N; Firoozabadi SM; Kafi-Abad SA; Mir LM
Radiol Oncol; 2012 Sep; 46(3):226-32. PubMed ID: 23077461
[TBL] [Abstract][Full Text] [Related]
19. Electrochemotherapy of radioresistant head and neck squamous cell carcinoma cells and tumor xenografts.
Zakelj MN; Prevc A; Kranjc S; Cemazar M; Todorovic V; Savarin M; Scancar J; Kosjek T; Groselj B; Strojan P; Sersa G
Oncol Rep; 2019 Mar; 41(3):1658-1668. PubMed ID: 30628709
[TBL] [Abstract][Full Text] [Related]
20. Electrotransfer of plasmid DNA radiosensitizes B16F10 tumors through activation of immune response.
Savarin M; Kamensek U; Cemazar M; Heller R; Sersa G
Radiol Oncol; 2017 Mar; 51(1):30-39. PubMed ID: 28265230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
